Related Experiment Video
Updated: May 22, 2026
06:04
Establishment and Confirmation of a Postnatal Right Ventricular Volume Overload Mouse Model
Published on: June 9, 2023
Right ventricular performance in congenital heart disease: a physiologic and pathophysiologic perspective
1Department of Medicine and Cardiology Unit, Pulmonary Hypertension and Adult Congenital Heart Disease Programs, Fletcher Allen Health Care, University of Vermont College of Medicine, McClure 1, MCHV Campus, 111 Colchester Avenue, Burlington, VT 05401, USA. william.hopkins@vtmednet.org
Cardiology Clinics
|May 3, 2012
Summary
The right ventricle significantly impacts long-term outcomes in congenital heart disease patients. Understanding its unique physiology and pathophysiology is crucial for managing these complex cardiac anomalies.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Congenital Heart Disease
Background:
- The right ventricle's role in congenital heart disease (CHD) morbidity and mortality is often underestimated.
- Right ventricular (RV) function in CHD is influenced by distinct physiological and pathophysiological factors.
- These factors differ significantly from those observed in acquired heart conditions.
Purpose of the Study:
- To highlight the critical importance of the right ventricle in long-term outcomes for patients with congenital heart disease.
- To explore the unique physiological and pathophysiological mechanisms governing right ventricular performance in CHD.
- To improve the understanding and management of diverse congenital cardiac anomalies.
Main Methods:
- Review of existing literature on right ventricular function in congenital heart disease.
- Analysis of physiological and pathophysiological factors specific to the right ventricle in CHD.
- Synthesis of information to elucidate the impact on patient morbidity and mortality.
Main Results:
- The right ventricle is frequently the primary driver of long-term adverse outcomes in CHD.
- Unique RV adaptations and dysfunctions are characteristic of various congenital cardiac anomalies.
- Current understanding often fails to adequately address these RV-specific challenges.
Conclusions:
- Enhanced understanding of RV physiology and pathophysiology in CHD is essential.
- This knowledge can lead to improved diagnostic and therapeutic strategies for congenital cardiac anomalies.
- Recognizing the RV's central role can significantly impact patient management and prognosis.
Related Concept Videos
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:29Pathophysiology of Cardiac Performance
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...